dc.contributor.author | Milman, Nils Thorm | |
dc.contributor.author | Schioedt, Frank Vinholt | |
dc.contributor.author | Junker, Anders Ellekaer | |
dc.contributor.author | Magnussen, Karin | |
dc.date.accessioned | 2019-12-11T14:40:56Z | |
dc.date.available | 2019-12-11T14:40:56Z | |
dc.date.created | 2019-10-08T13:50:21Z | |
dc.date.issued | 2019 | |
dc.identifier.citation | Gastroenterology Research. 2019, 221-232. | |
dc.identifier.issn | 1918-2805 | |
dc.identifier.uri | http://hdl.handle.net/11250/2632805 | |
dc.description.abstract | This paper outlines the Danish aspects of HFE-hemochromatosis, which is the most frequent genetic predisposition to iron overload in the five million ethnic Danes; more than 20,000 people are homozygous for the C282Y mutation and more than 500,000 people are compound heterozygous or heterozygous for the HFE-mutations. The disorder has a long preclinical stage with gradually increasing body iron overload and eventually 30% of men will develop clinically overt disease, presenting with symptoms of fatigue, arthralgias, reduced libido, erectile dysfunction, cardiac disease and diabetes. Subsequently the disease may progress into irreversible arthritis, liver cirrhosis, cardiomyopathy, pancreatic fibrosis and osteoporosis. The effective standard treatment is repeated phlebotomies, which in the preclinical and early clinical stages ensures a normal survival rate. Early detection of the genetic predisposition to the disorder is therefore important to reduce the overall burden of clinical disease. Population screening seems to be cost-effective and should be considered. | en |
dc.description.sponsorship | This study was supported by unrestricted grants from The Danish Haemochromatosis Association (Dansk Haemokromatose Forening) www.haemokromatose.dk and Pharmovital ApS, Rosenkaeret 11B, DK-2860 Soeborg, Denmark. | en |
dc.language.iso | eng | |
dc.publisher | Elmer Press | |
dc.rights | Navngivelse-Ikkekommersiell 4.0 Internasjonal | * |
dc.rights.uri | http://creativecommons.org/licenses/by-nc/4.0/deed.no | * |
dc.subject | Arthritis, Diabetes mellitus, Hemochromatosis type 1, HFE-associated hemochromatosis, Hereditary hemochromatosis, Hepatocellular carcinoma, Iron overload, Liver cirrhosis | en |
dc.title | Diagnosis and Treatment of Genetic HFE-Hemochromatosis: The Danish Aspect | en |
dc.type | Journal article | en |
dc.description.version | publishedVersion | |
dc.rights.holder | Articles © The authors | Journal compilation © Gastroenterol Res and Elmer Press Inc™ | www.gastrores.org This article is distributed under the terms of the Creative Commons Attribution Non-Commercial 4.0 International License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited | en |
dc.source.pagenumber | 221-232 | nb_NO |
dc.source.volume | 12 | nb_NO |
dc.source.journal | Gastroenterology Research | en |
dc.source.issue | 5 | nb_NO |
dc.identifier.doi | 10.14740/gr1206 | |
dc.identifier.cristin | 1734961 | |
cristin.unitcode | 1991,0,0,0 | |
cristin.unitname | Sykehuset Innlandet HF | |
cristin.ispublished | true | |
cristin.qualitycode | 0 | |